Health
Abu Dhabi Consolidates Pharma Assets, Sets Sights on M&A
The new entity will include Egypt’s Amoun Pharmaceutical Co., Switzerland’s Acino International and Turkey’s Birgi Mefar Group.
Photographer: Joe Raedle/Getty ImagesThis article is for subscribers only.
Abu Dhabi sovereign wealth fund ADQ is consolidating some of its pharmaceutical assets to create one of the region’s largest life sciences firms, with operations across four continents.
The new entity will include Egypt’s Amoun Pharmaceutical Co., Switzerland’s Acino International and Turkey’s Birgi Mefar Group. Arcera, as the holding company will be called, will have a combined workforce of more than 6,500 people across 90 countries.